Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
703.00
505.00
463.00
461.00
357.00
193.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
703.00
505.00
463.00
461.00
357.00
193.00
Expenditure (Ex Depriciation)
Stock Adjustments
-71.00
-54.00
-7.00
-26.00
-22.00
-6.00
Raw Materials Consumed
691.00
494.00
430.00
457.00
358.00
184.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
7.00
4.00
3.00
2.00
2.00
1.00
Operating Expenses
5.00
4.00
8.00
8.00
5.00
3.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1.00
1.00
1.00
1.00
1.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
2.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
651.00
466.00
440.00
446.00
346.00
186.00
Operating Profit (PBDIT) excl Other Income
51.00
39.00
22.00
14.00
10.00
7.00
Other Income
8.00
2.00
2.00
1.00
0.00
0.00
Operating Profit (PBDIT)
60.00
41.00
25.00
15.00
11.00
7.00
Interest
25.00
16.00
8.00
5.00
3.00
3.00
Profit before Depriciation and Tax
34.00
25.00
16.00
10.00
8.00
4.00
Depreciation
3.00
2.00
1.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
30.00
22.00
15.00
9.00
7.00
3.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
30.00
20.00
15.00
9.00
7.00
3.00
Provision for Tax
7.00
5.00
3.00
2.00
1.00
0.00
Profit After Tax
23.00
14.00
11.00
7.00
5.00
2.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
46.00
31.00
19.00
12.00
6.00
4.00
Profit Available for appropriations
69.00
46.00
30.00
19.00
12.00
6.00
Appropriations
69.00
46.00
30.00
19.00
12.00
6.00
Equity Dividend (%)
0.00%
0.00%
0.00%
3.00%
0.00%
0.00%
Earnings Per Share
0.97
0.62
0.48
5.48
5.46
2.74
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 39.21% vs 8.95% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 31.48% vs 71.09% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 60.19% vs 79.37% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 56.17% vs 30.64% in Mar 2025
Compare Profit and Loss Results of Sudarshan Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
703.00
239.00
464.00
194.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
703.00
239.00
464.00
194.14%
Expenditure (Ex Depriciation)
Stock Adjustments
-71.00
-1.00
-70.00
-7,000.00%
Raw Materials Consumed
691.00
174.00
517.00
297.13%
Power & Fuel Cost
0.00
7.00
-7.00
-100.00%
Employee Cost
7.00
6.00
1.00
16.67%
Operating Expenses
5.00
7.00
-2.00
-28.57%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
1.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
651.00
203.00
448.00
220.69%
Operating Profit (PBDIT) excl Other Income
51.00
35.00
16.00
45.71%
Other Income
8.00
2.00
6.00
300.00%
Operating Profit (PBDIT)
60.00
37.00
23.00
62.16%
Interest
25.00
0.00
25.00
0%
Profit before Depriciation and Tax
34.00
37.00
-3.00
-8.11%
Depreciation
3.00
9.00
-6.00
-66.67%
Profit Before Taxation & Exceptional Items
30.00
27.00
3.00
11.11%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
30.00
27.00
3.00
11.11%
Provision for Tax
7.00
5.00
2.00
40.00%
Profit After Tax
23.00
22.00
1.00
4.55%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
46.00
15.00
31.00
206.67%
Profit Available for appropriations
69.00
37.00
32.00
86.49%
Appropriations
69.00
37.00
32.00
86.49%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
0.97
18.11
-17.14
-94.64%
Profit And Loss - Net Sales
Net Sales 703.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 39.21% vs 8.95% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.48% vs 71.09% in Mar 2025
Profit And Loss - Interest
Interest 25.70 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 60.19% vs 79.37% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 23.37 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 56.17% vs 30.64% in Mar 2025